XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 38,098 $ (14,623)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 12,519 13,617
Amortization of debt discount 7,611 7,239
Amortization of deferred debt issuance costs 2,946 2,697
Amortization 40,747 40,973
Stock-based compensation 12,003 10,119
Deferred income taxes (1,311) (786)
Loss on early extinguishment of debt 899 0
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable 9,890 21,574
Inventories (34,679) (19,396)
Accounts payable (6,223) 1,477
Accrued compensation and benefits 5,030 (8,864)
Other assets (15,915) (6,013)
Other liabilities 6,370 (3,628)
Net cash provided by operating activities 77,985 44,386
Cash flows from investing activities:    
Proceeds from sale of a facility 0 3,227
Purchases of property, plant and equipment (11,678) (9,864)
Payments related to business and asset acquisitions, net of cash acquired 0 (3,852)
Net cash used in investing activities (11,678) (10,489)
Cash flows from financing activities:    
Payments on term loan (63,673) (9,938)
Proceeds from term loan 52,411 0
Payments on revolving line of credit (272,753) (142,000)
Proceeds from revolving line of credit 236,753 152,000
Payments for Contingent Consideration (3,536) (2,071)
Payments related to debt issuance costs (2,000) (2,057)
Dividends paid on common stock (17,418) (17,099)
Other, net 9,457 (3,730)
Net cash used in financing activities (60,759) (24,895)
Effect of exchange rate changes on cash and cash equivalents (1,393) 740
Net increase in cash and cash equivalents 4,155 9,742
Cash and cash equivalents at beginning of period 27,356 25,856
Cash and cash equivalents at end of period 31,511 35,598
Non-cash investing and financing activities:    
Dividends payable $ 5,837 $ 5,720